Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

The pandemic worsened physical and mental challenges for women with PCOS.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Most people with post-COVID syndrome experience symptoms like fatigue, but Omicron variants cause fewer persistent symptoms.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

A machine learning model can predict alopecia areata early using specific gene markers.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Researchers found four genes that could help diagnose severe alopecia areata early.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Health workers in non-COVID wards had higher depression and anxiety rates.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.